Who Paid My Doc
A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological ad clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications.
Research payments
$5,661,510
Through program year 2021, $5,661,510 in research payments was reported against A Phase I, open-label, multiple-ascending dose trial to investigate the safety, tolerability, pharmacokinetics, biological ad clinical activity of MSB0010718C in subjects with metastatic or locally advanced solid tumors and expansion to selected indications., across 977 payments, paid by EMD Serono, Inc..
- Paid by
- EMD Serono, Inc.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2021 | Research | $131,942 | 19 |
| 2020 | Research | $5,529,568 | 958 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- John Morris Cincinnati, OH Named on 181 payments
- Nicholas Iannotti Port St Lucie, FL Named on 70 payments
- Janice Mehnert New Brunswick, NJ Named on 61 payments
- Chandra Belani Hershey, PA Named on 50 payments
- Howard Safran Providence, RI Named on 42 payments
- Jigarkumar Parikh Augusta, GA Named on 40 payments
- Matthew Taylor Portland, OR Named on 32 payments
- Vasileios Assikis Newnan, GA Named on 25 payments
- Ding Wang Detroit, MI Named on 24 payments
- Theodore Gourdin Charleston, SC Named on 23 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.